Nightingale Health Oyj (HEL:HEALTH)
0.8580
+0.0340 (4.13%)
At close: Jul 27, 2026
Nightingale Health Oyj Cash Flow Statement
Financials in millions EUR. Fiscal year is July - June.
Millions EUR. Fiscal year is Jul - Jun.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Net Income | -19.07 | -18.46 | -17.46 | -18.08 | -16.09 | -9.73 |
Depreciation & Amortization | 7.32 | 8.29 | 8.16 | 6.69 | 4.24 | 2.45 |
Stock-Based Compensation | 1.28 | 1.69 | 2.93 | 3.95 | 3.53 | 3.73 |
Other Adjustments | 0.61 | -0.74 | -1.14 | -0.67 | 2.48 | -0.15 |
Change in Receivables | -1.41 | -0.15 | -0.52 | -0.15 | -0.55 | 0.38 |
Changes in Inventories | -0.61 | -1.04 | -0.15 | 0.04 | 0.07 | -0.47 |
Changes in Accounts Payable | 0.75 | 0.2 | 0.06 | 0.37 | -0.33 | 2.19 |
Changes in Income Taxes Payable | -0.03 | -0.05 | -0.11 | -0.01 | -0 | -0 |
Changes in Other Operating Activities | 0.26 | 0.15 | -0.17 | 0.53 | -0.82 | -0.27 |
Operating Cash Flow | -10.92 | -10.11 | -8.41 | -7.33 | -7.47 | -1.87 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Capital Expenditures | -4.34 | -4.15 | -4.59 | -4.41 | -1.37 | -0.9 |
Purchases of Intangible Assets | - | - | - | - | -6.24 | -2.44 |
Purchases of Investments | -9.88 | -58.67 | -91.39 | - | - | -3.27 |
Proceeds from Sale of Investments | 47.2 | 71.17 | 69.03 | - | - | - |
Cash Acquisitions | - | - | 0.04 | - | -0.71 | - |
Other Investing Activities | 0.52 | 1.13 | 1.37 | - | - | - |
Investing Cash Flow | 33.49 | 9.47 | -25.54 | -4.41 | -8.32 | -6.61 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Short-Term Debt Issued | - | - | - | - | - | 8.79 |
Net Short-Term Debt Issued (Repaid) | - | - | - | - | - | 8.79 |
Long-Term Debt Issued | - | - | - | - | - | 7.82 |
Long-Term Debt Repaid | -0.26 | -0.3 | -1.11 | -1.53 | -1.86 | -0.78 |
Net Long-Term Debt Issued (Repaid) | -0.26 | -0.3 | -1.11 | -1.53 | -1.86 | 7.04 |
Issuance of Common Stock | 0.02 | 0.03 | - | - | 0.47 | 105.82 |
Repurchase of Common Stock | - | - | - | - | - | -0.02 |
Net Common Stock Issued (Repurchased) | 0.02 | 0.03 | - | - | 0.47 | 105.8 |
Other Financing Activities | -1.43 | -1.32 | -1.71 | -1.05 | -1.47 | -0.25 |
Financing Cash Flow | -1.68 | -1.58 | -2.83 | -2.58 | -2.86 | 121.38 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Foreign Exchange Rate Adjustments | -0.47 | -0.14 | -0.22 | -0.32 | 0.13 | - |
Net Cash Flow | 20.9 | -2.23 | -36.77 | -14.32 | -18.66 | 112.9 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Free Cash Flow | -15.26 | -14.26 | -13 | -11.74 | -8.85 | -2.77 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | -318.24% | -303.90% | -298.21% | -280.80% | -382.49% | -120.04% |
Free Cash Flow Per Share | -0.25 | -0.24 | -0.22 | -0.19 | -0.15 | -0.07 |
Levered Free Cash Flow | -16 | -15.36 | -15.38 | -16.4 | -16.16 | 9.11 |
Unlevered Free Cash Flow | -15.68 | -15.94 | -15.33 | -15.3 | -11.93 | -6.75 |